Healthtech & Wellness VC Funds

Pritzker Group, founded by the Pritzker family, is a diversified investment firm with a robust portfolio spanning private capital, venture capital, and asset management. Their investment strategies leverage a permanent capital base, allowing for flexible, long-term investments without the constraints of traditional funding timelines. This approach benefits from the Pritzkers' extensive network, which includes access to advisors, strategic partners, and customers. Notable investments by Pritzker Group Venture Capital include high-profile companies such as Coinbase, SMS Assist, and SpotHero. The group focuses on sectors such as vertical SaaS, marketplaces, and healthtech, supporting companies from seed to growth stages. Their portfolio also includes companies like Cameo and G2 Crowd, showcasing their emphasis on innovative, scalable businesses. The private capital division of Pritzker Group focuses on acquiring and building leading middle-market companies in North America, with investments in industries like manufacturing, logistics, life sciences, and healthcare. Significant investments include firms like TMS International and STV Inc. Pritzker Group's asset management arm allocates capital globally to top-tier investment managers, providing diversified and strategic growth opportunities. Their comprehensive support for portfolio companies includes strategic guidance and leveraging their extensive network to accelerate growth and innovation​.

Privilege Ventures SA is a Swiss, FINMA-authorized early-stage venture capital firm founded in 2016 and headquartered in Lugano, Switzerland, with additional offices in Zurich and Boston. It is the venture capital arm of Privilege Management and is widely recognized as Switzerland's first female-led venture capital firm. The firm's investment thesis is grounded in a data-driven rationale: gender-mixed teams and women-led companies produce better financial outcomes, and Privilege frames this as an economic-return argument rather than a fairness one. The team of approximately ten people, including four Partners and two Venture Partners, spans Switzerland and Italy and brings deep expertise in entrepreneurship, management, finance, and governance. Privilege Ventures invests at seed and early-stage across three thematic pillars: healthtech, agrifood technology, and cleantech, with additional exposure to industrial tech, med-tech, wearables, and broader ICT. Its geographic footprint covers Switzerland and the rest of Europe, with selective Boston-based investments. The firm has approximately 40 portfolio companies. Notable names include Xsensio (wearable skin-chemistry monitoring, most recent disclosed investment March 2026), Adiposs (CHF 4 million Series A, June 2025), AgroSustain, Enantios, SONIX (May 2025), and SMEETZ (March 2025). Beyond capital, Privilege Ventures provides strategic support and mentorship throughout the investment lifecycle, with particular depth in helping portfolio companies navigate Swiss and European regulatory environments and institutional sales. Its status as Switzerland's first female-led VC has generated a differentiated LP base and a co-investor network that values diversity-aligned deal flow, creating a reinforcing pipeline advantage in sourcing and winning competitive seed rounds from underrepresented founding teams across the European life sciences and deep-tech ecosystem.

Procter and Gamble Ventures is the in-house startup studio of Procter and Gamble (NYSE: PG), the $80 billion-plus consumer-packaged-goods multinational. Founded in 2015 and operating from P&G's global headquarters in Cincinnati, Ohio, the studio was designed around a specific thesis: combine the agility of a startup with P&G's expertise, scale, and science to create genuinely new-to-the-world consumer brands targeting multi-billion-dollar categories of unmet need. P&G describes this as 'constructive disruption' — building new categories rather than new SKUs within existing ones. The studio develops both internal P&G-originated ideas and external founder-led ideas, embedding early-stage startups with P&G's R&D capabilities, brand marketing resources, supply chain, and global distribution network. Strategic verticals currently include pest control, lawn and garden, and pet parenting, with selective adjacencies in skincare and personal care. Portfolio and brand highlights include Zevo (people-friendly bug control — P&G Ventures' first major breakout, which reached $100 million in sales and became America's fastest-growing pest control brand), Spruce (pet and bee-safe weed killer, launched 2025), Opte (precision skincare device), Metaderm (skincare), Kindra (menopause care), and LoveIt. PitchBook and Crunchbase list approximately 8 disclosed investments. P&G Ventures' model is structurally distinct from traditional corporate venture: rather than making minority equity investments and remaining passive, the studio actively co-creates brands, funds their development, and manages their commercial launch using P&G infrastructure. This approach significantly de-risks the path from idea to shelf for early-stage consumer founders, but also means P&G retains significant operational control. For founders aligned with the consumer-goods category and seeking access to the world's largest CPG distribution network, the studio offers an unmatched commercial platform.

Co-Op Ventures is a venture capital firm with a focus on early-stage investments, particularly in technology-driven sectors such as B2B SaaS, cloud infrastructure, and fintech. Based in the Pacific Northwest, the firm targets high-growth startups that demonstrate innovation and scalability potential across a variety of industries. Co-Op Ventures is known for its hands-on approach to investing. They actively support their portfolio companies, providing not only capital but also strategic guidance and deep operational involvement. With a focus on long-term value creation, Co-Op often leads funding rounds and partners closely with founders, helping them navigate challenges from initial funding stages through growth and scaling phases. The firm’s portfolio reflects its commitment to innovation and technology, featuring investments in sectors such as cloud computing, AI, and data-driven services. The firm operates with a "patient capital" philosophy, emphasizing long-term partnerships over quick returns. This aligns with their goal of nurturing companies that can grow sustainably over time, avoiding the rapid cycles often associated with more aggressive venture strategies. Co-Op Ventures typically invests in seed and Series A stages, positioning itself as a key player in the tech ecosystems of the Pacific Northwest and beyond. Their expertise and dedication to helping founders build successful companies have made them a prominent name in early-stage venture capital.

Progression is the TikTok alumni fund. We write first checks in visionary consumer tech founders. Consumer tech is at the beginning of a Super Cycle driven by AI. We are investing in a new wave of founders who are building AI native products that are transforming the lives of everyday consumers.

Project A Ventures, founded in 2012 and based in Berlin, is a leading early-stage venture capital firm. The firm is renowned for its "operational VC" model, which goes beyond providing capital by offering extensive operational support through its team of over 140 functional experts. This team helps portfolio companies excel in areas such as tech, growth, data, and people. Project A focuses on sectors like fintech, digital health, logistics, eCommerce, proptech, B2B enterprise software, and mobility. They invest from pre-seed to Series A stages, with initial investments ranging from $1 million to $10 million, and reserves up to $30 million for future rounds. Their latest fund, which closed at $375 million, brings their total assets under management to $1 billion. Notable portfolio companies include Trade Republic, Kry, sennder, WorldRemit, Spryker, and Voi​.

Prolog Ventures is a U.S.-based venture capital firm that focuses on early-stage investments in health, wellness, and sustainability. With offices in St. Louis and San Francisco, Prolog has a strong track record of backing startups that promote healthier lives and a healthier planet. Notable investments include Plum Organics, a pioneer in organic baby food, and Benson Hill, an agricultural tech innovator. Their portfolio spans consumer health, agtech, and wellness products. Prolog Ventures primarily targets startups in North America, with a particular emphasis on business models that enhance well-being through innovative ingredients, products, and delivery mechanisms. Their partnership with Lonza extends their reach into functional foods, dietary supplements, and personal care. Prolog's strategy revolves around investing in visionary companies that align with their ethos of supporting healthy living. The firm prefers to get involved early, often leading rounds with check sizes ranging from $500K to $5 million. They value long-term partnerships and often leverage their deep network in healthcare and consumer products to help portfolio companies scale. The team is led by co-founders Greg Johnson, Brian Clevinger, and Ilya Nykin, all of whom bring decades of expertise in life sciences and venture capital.

Promus Ventures is a venture capital firm specializing in early-stage investments in deep-tech software and hardware companies. Founded in 2012, the firm has a global focus with offices in Chicago, San Francisco, and Luxembourg. Promus Ventures targets innovative sectors such as space technology, artificial intelligence, and advanced manufacturing. The firm has an impressive portfolio that includes notable companies like Rocket Lab, Mapbox, and Whoop. Rocket Lab, a leading space launch provider, and Whoop, a performance optimization wearable, are among their most successful investments, both achieving unicorn status. Promus Ventures also invests in companies like ICEYE, which operates the largest synthetic-aperture radar (SAR) satellite constellation. Promus Ventures' investment strategy emphasizes backing visionary and tenacious founding teams. They focus on transformative technologies with the potential to digitize mature industries and create significant market impact. Their approach involves close collaboration with portfolio companies, providing strategic guidance and leveraging their extensive network to support growth and scalability. The leadership team includes Mike Collett, based in Chicago, Pierre Festal in Luxembourg, and Gareth Keane in Santa Clara, each bringing extensive experience in technology and venture capital. The firm’s commitment to deep-tech and its global perspective make it a significant player in the venture capital landscape.

PROOF is a venture capital firm founded in 2015 and based in Reston, Virginia, with a unique approach to investing. The firm specializes in pro-rata rights investments, meaning they take advantage of opportunities to invest in later rounds of top-performing companies originally backed by early-stage VCs. By leveraging these pro-rata rights, PROOF ensures that early investors stay involved in their best companies while securing access to high-growth businesses for themselves. Their portfolio spans a wide array of industries, including fintech, enterprise software, healthtech, and gaming. Notable investments include companies like ICON, which uses 3D printing for affordable housing, Jackpocket, a mobile lottery app, and Dragos, a leader in industrial cybersecurity. PROOF's investment approach is industry-agnostic, allowing them to back some of the most promising companies across sectors like consumer products, enterprise solutions, and digital health. The firm is led by co-founders John Backus and Thanasis Delistathis, both of whom bring deep expertise in venture capital and finance. PROOF's strategy has been successful, with the firm raising $135 million for its third fund in 2023. Their goal is to build a "greatest hits" portfolio, with a focus on ensuring that the majority of their investments contribute meaningfully to returns, flipping the traditional VC model.

Propel Venture Partners is a venture capital firm dedicated to investing in the new financial economy. Founded in 2016, Propel focuses on early-stage investments ranging from pre-seed to Series A, with typical investment amounts between $1.5 million and $12 million. The firm targets startups that enable, accelerate, deliver, and secure financial services across the Americas, including the US, Brazil, and Mexico. Propel's portfolio features a diverse array of innovative companies such as Brave, Coinbase, Groww, and Guideline. These companies are at the forefront of financial technology and digital services, spanning sectors like blockchain, fintech, and digital payments. The Propel team is led by experienced professionals including General Partners Jay Reinemann and David Mort. Jay has over two decades of experience in early-stage investing, with a background at Visa and BBVA. David brings a decade of venture capital experience from his time at SVB and BBVA. Propel offers a collaborative approach to investing, willing to both lead and follow in funding rounds while actively supporting the growth of their portfolio companies.

Propel(x), co-founded by Swati Chaturvedi and Lisheng Wang, is an online investment platform that connects science and technology startups with accredited investors. The platform focuses on deep tech startups in sectors such as energy, green technology, aerospace, life sciences, IT, communications, industrial technologies, and financial services. Notable investments facilitated through Propel(x) include Brelyon, which develops immersive display technology with backing from Lockheed Martin and the E14 Fund, and BlockApps, an enterprise blockchain platform supported by Morgan Creek and Liberty City Ventures. Repurpose, a company working to reduce single-use plastics, is another example, with investors like Chaifetz Group and SWAT Equity Partners. Ligandal, a biotech firm specializing in regenerative medicine and pandemic defense technology, also raised capital on the platform with support from Y Combinator and Techstars. Propel(x) offers Special Purpose Vehicles (SPVs) to pool funds, allowing investors to meet higher investment minimums. This approach democratizes access to early-stage investments in groundbreaking technologies. The platform ensures comprehensive due diligence and curated deal flow, providing investors with well-vetted startups. Propel(x) has been recognized for making early investment opportunities accessible to a broader range of investors.

Prospect Venture Partners is a Palo Alto, California-based life-sciences venture capital firm founded in 1997 by Alex Barkas, Ph.D. and David Schnell, M.D., both formerly of Kleiner Perkins Caufield and Byers. Since inception, the firm has raised more than $1 billion of committed capital from foundations, endowments, pension funds, and other institutional limited partners across three flagship funds — Prospect Venture Partners I through III — making it one of the most established dedicated biomedical venture firms on the West Coast. The four Managing Partners are Alex Barkas, David Schnell, Russell Hirsch, M.S., Ph.D., and Jim Tananbaum, M.D., together representing decades of combined life-sciences venture experience. Prospect leads rounds and ultimately invests $10 million to $20 million per company across new-company incubations, first and second venture financings, and later-stage private and public expansion capital. The firm's mandate is commercially attractive biomedical enterprises with outstanding entrepreneurial management teams, proprietary products, and innovative technologies. Across its history, Prospect has recorded approximately 161 investments and 38 portfolio exits. Notable exits include Amira Pharmaceuticals (acquired by Bristol-Myers Squibb for $475 million in 2011) and Gloucester Pharmaceuticals (acquired by Celgene for $640 million in December 2009). The most recent disclosed exit was Nanosys in September 2023. Prospect's founding pedigree — two Kleiner Perkins partners building an independent life-sciences franchise in 1997 — gave the firm early access to the first generation of genomics and biotechnology companies and established LP and syndication relationships that have compounded over nearly three decades. Though the firm did not close a Fund IV and is not making new primary bets, its existing portfolio and governance roles continue to generate activity across its established base of biotech, pharma, and medical-device holdings.

Protagonist is a venture capital firm that focuses on backing early-stage, emerging technology companies, with a particular emphasis on blockchain, fintech, artificial intelligence, and crypto-related projects. Founded in 2022 and based in Bay Harbor Islands, Florida, Protagonist is led by experienced co-founders George Bousis, Harry Hurst, George Ruan, and the Macalinao brothers, known for their involvement with Solana. Protagonist takes a hands-on approach, actively supporting founders with fundraising, product development, strategy, and business scaling. Their portfolio includes notable investments in blockchain companies such as Aptos Labs, Eigenlayer, and Exowatt, all leaders in their respective niches. In 2022, they raised a $100 million fund aimed specifically at early-stage blockchain and gaming startups, a testament to their belief in the future potential of the digital asset space. Protagonist stands out for its commitment to working closely with founders, offering deep operational expertise to help build scalable, high-impact businesses.

Protege Ventures (PV) is Southeast Asia's first — and Singapore's only — student-run venture capital fund, established in 2017 by Singapore Management University's Institute of Innovation and Entrepreneurship and headquartered in central Singapore. PV operates simultaneously as an active early-stage investor deploying real capital into student-founded startups and as a nationwide training programme for aspiring student venture capitalists drawn from polytechnics and universities across Singapore. Selected students commit to a minimum one-year full-immersion experience covering sourcing, due diligence, investment committee memos, and portfolio support, under the guidance of SMU faculty and industry mentors. PV is industry-agnostic and invests at pre-seed to seed stages via convertible notes, with typical ticket sizes of SGD 25,000 to SGD 50,000. Since 2017, PV has deployed over $300,000 across 12 student-founded startups. Notable portfolio companies include Lumitics (IoT food-waste management), Hypotenuse AI (AI content writer), Intellect (Asia's largest mental-health care app), Angie's Tempeh (plant-based protein), ZOLO (AI B2B software for food suppliers, pre-seed 2024), and Equatorial Space Systems (PV's first space-tech investment, August 2024). Portfolio sectors span AI, food technology, mental health, consumer services, and space. Protege Ventures' dual mandate — generating financial returns while training the next generation of Southeast Asian venture investors — creates a distinctive institutional model that no conventional fund replicates. For portfolio founders, PV's student investor base translates to a particularly engaged cohort of early believers who bring fresh analytical energy, a wide university network, and long-term personal commitment to each company's success. The programme's tight connection to SMU and the broader Singaporean university system makes it a natural first port of call for exceptional student and recent-graduate founders in the city-state.

Prototype Capital is a venture capital firm founded in 2015 with a mission to back early-stage companies that apply new technologies, such as machine learning, to traditional industries like healthcare, insurance, and transportation. Headquartered in the United States, with additional presence in India, the firm prides itself on being deeply involved with its portfolio companies. Prototype Capital doesn't just provide financial backing; they also offer hands-on support in the trenches alongside founders, helping them build long-lasting, impactful businesses. The firm focuses on identifying ambitious founders across the globe, having invested in 12 companies across sectors such as retail, enterprise applications, and real estate technology. Notable portfolio companies include FaZe Clan, one of the largest e-sports teams globally, Hightouch, a customer data management platform, and Ghost Robotics, known for their autonomous unmanned ground vehicles. Prototype Capital's portfolio companies have collectively raised over $300 million and generated significant value, highlighting the firm’s successful track record. What sets Prototype Capital apart is its commitment to founders, offering support in key decisions like hiring, scaling operations, and building partnerships with Fortune 500 companies. The firm also provides additional resources such as free access to tools and services, corporate partnerships, and press opportunities, ensuring their portfolio companies have everything they need to succeed in competitive markets.

Proxima Ventures is a Shanghai, China-headquartered healthcare-specialist venture capital firm founded in 2015. The firm's mission is to improve the health and lives of people worldwide by investing in emerging global healthcare technologies — with thematic concentration across biotechnology, novel therapeutics, medical devices, diagnostics, clinically significant digital healthcare solutions, advanced data analytics platforms, and innovative business models emerging from China's healthcare system reform. Proxima manages multiple funds denominated in both Chinese RMB and US dollars and is stage-agnostic within healthcare — deploying capital across angel, early, and growth-stage rounds with follow-on support through downstream financing. The firm is led by Founding Partner and Managing Partner George Li and Partner Haolin Sung. As of late 2025, Proxima Ventures has made approximately 105 disclosed investments, with consistent recent activity across surgical devices, drug discovery, and digital health. Notable recent deals include Shengxin Medical (surgical devices, most recent disclosed investment, November 2025), BridGene Biosciences (Series B-II, October 2025), Rapafusyn Pharmaceuticals (participated in a $28 million Series A in June 2024 — non-degrading molecular glue drug discovery), and Bioelectronica Corporation (co-invested with Co-win Ventures to accelerate pharmaceutical discovery and development). Proxima's team brings deep operating and investing experience in the life sciences industry alongside an extensive clinical and industrial network inside China. This local knowledge is a meaningful asset: China's healthcare system reform, aging population, and accelerating biotech research ecosystem create deal-flow dynamics and regulatory pathways that require genuine on-the-ground expertise to navigate. The firm's RMB-and-USD dual-currency structure allows it to invest efficiently across both domestic Chinese companies and internationally-oriented biotechs with China market ambitions.

Proximity Ventures is a New York-based venture capital firm formed in late 2024 and publicly launched in October of that year. It was co-founded by Neil Sirni — formerly of Roc Nation's venture division Arrive, where he led investments into Sweetgreen, Robinhood, Epic Games, and SpaceX — alongside Jason Mack (formerly of Mack Ventures), musician Santi White (Santigold), and actor and director Olivia Wilde. The firm targets early- and growth-stage companies across the United States and Southeast Asia, with teams operating across Europe, the US, and Asia, and takes a hands-on, founder-first approach built around long-term relationships with operators. Proximity's capital strategy splits into two distinct vehicles: an early-stage fund writing approximately eight equity checks per year at $500,000 to $2 million, and a growth-stage fund targeting approximately $100 million that writes checks of $10 million to $25 million roughly four times per year. Approximately 75% of capital deploys into US-based companies, with most foreign exposure concentrated in Southeast Asia. Sector coverage is broad, spanning software, real estate services, financial software, consumer, and wellness. Across the predecessors' and the current platform's combined history, the partners have invested in more than 200 companies. Disclosed Proximity Ventures portfolio investments include Pendulum Therapeutics (consumer health and probiotics), Delphi, Spleet, and Kredi. The firm's co-founder composition — combining an institutional venture operator, a entertainment-industry entrepreneur, a musician, and a filmmaker — is designed to give Proximity access to founder networks, cultural moments, and consumer behavior insights that pure financial investors lack. For founders building at the intersection of technology, culture, and consumer behavior, this cross-disciplinary team is a distinctive draw beyond the capital itself.

PS27 Ventures is a Jacksonville, Florida-based early-stage venture capital and startup leadership-training firm founded in 2013 by Jim Stallings, who serves as CEO and General Partner. The firm is veteran-owned and veteran-operated, and positions itself as both a capital provider and a hands-on accelerator of founder growth. PS27 Ventures invests into early-stage, high-growth technology companies across fintech, healthtech, e-commerce, climate tech, and B2B SaaS, with recent strategy concentrated heavily on artificial intelligence — roughly 80% of its Titan Fund deployments are into AI-native businesses, with particular concentration in AI-powered B2B SaaS and fintech. The PS27 Titan Fund is a $25 million vehicle investing at seed and Series A with typical check sizes of $250,000 to $1 million. The core team includes Hale Bullen (Investment Manager), Shannon Mayo (Operations Manager), and Ron Burgess (Finance, with over 40 years of fiscal and organizational experience) alongside Stallings. Across its history, PS27 has invested in 37 companies. Named recent investments include Quickcode AI (trade-compliance management systems, co-invested with DataTribe — subsequently raised a $1.4 million round led by Buckhorn Capital Group) and Neural Payments (an Ohio-based AI fintech into which PS27 committed $500,000-plus alongside FIS as both co-investor and strategic partner). PS27's Jacksonville base is a deliberate choice: Stallings believes the Southeast United States remains significantly undercapitalized relative to coastal innovation hubs, and that founders building there often combine strong product fundamentals with access to operating-cost advantages unavailable in San Francisco or New York. The affiliated PS27 Foundation extends this mission into community impact, reflecting Stallings' personal commitment to entrepreneurship as a vehicle for economic opportunity across underserved regions.

PSL Ventures is the early-stage venture capital arm of Pioneer Square Labs (PSL), a Seattle-based startup studio and venture firm founded in 2015. The platform operates a dual model: PSL Studio ideates and spins out new technology companies from scratch — including Studio III, a $20 million fund with a generative-AI thesis that closed in 2023 — while PSL Ventures invests in both PSL-incubated companies and external pre-seed, seed, and Series A startups. PSL Ventures has raised Fund I at $80 million (oversubscribed) and Fund II at $100 million (oversubscribed), managing more than $180 million across the venture platform. The firm leads rounds and deploys checks from $500,000 to $5 million. The fund focuses on technology-driven companies, with an emphasis on the Pacific Northwest and a current thesis around large-language-model-enabled AI. Across eight-plus years, the PSL Studio has spun out 33 venture-backed companies; PSL Ventures has made 60 investments in total. Notable portfolio companies include Boundless (immigration technology) and Kevala (healthcare staffing). PSL Ventures is led by four Managing Directors: Greg Gottesman (former Madrona MD and co-founder of Rover.com), Julie Sandler (former Madrona partner and ex-Amazon), Mike Galgon (aQuantive co-founder and CSO), and Geoff Entress (ex-Voyager Capital). Beyond capital, PSL Ventures draws on a 22-person team of company-builders spanning engineering, design, product, marketing, analytics, and recruiting to support portfolio companies. In 2024 the firm integrated generative AI into its validation workflow, cutting concept cycle times by approximately 40 percent and enabling five times more idea testing compared to 2019. The combined studio-plus-fund structure gives founders access to an unusually deep bench of operational resources from day one.

PSV Tech01 is the flagship venture capital fund of PreSeed Ventures (PSV) — Denmark's largest and most experienced pre-seed investor. PreSeed Ventures was founded in 2000 at DTU (Technical University of Denmark), where it originated as DTU Innovation, and is still owned by DTU, headquartered in Kongens Lyngby in Greater Copenhagen. PSV operates as a 'venture house' — a coordinated collection of funds and platforms designed to act as the first institutional investor on the cap table for Danish and Southern Swedish startups. PSV Tech01 is a EUR 55 million software-oriented pre-seed fund launched in December 2021 to back approximately 40 early-stage startups over four years. PSV Hafnium — Denmark's first dedicated deep-tech venture fund, launched in 2024 with a EUR 80 million hard cap — targets science-based cleantech, healthtech, and next-generation industrial solutions, with a first close of EUR 38.1 million in October 2024 backed by the European Investment Fund and EIFO. Since inception in 2000, PSV has financed and assisted over 400 startups and made 141 disclosed investments; more than 75% of portfolio companies go on to raise follow-on capital. Notable portfolio successes include Vivino, Trustpilot, Lunar, Seaborg Technologies, and Glycom. The firm leads rounds at pre-seed and seed and operates through a broad co-investor network including Creandum, Seed Capital, Northzone, Vækstfonden, Howzat Partners, Merck Ventures, and the Lundbeck Foundation. PSV's DTU ownership gives it a structurally privileged position in the Danish innovation ecosystem: the university relationship generates direct access to research commercialization opportunities, faculty founders, and student entrepreneurs before they enter the broader market. This pipeline advantage compounds over time and has enabled PSV to be the defining first investor in some of Denmark's most successful technology companies.

PsyMed Ventures is a venture capital firm focused on transforming mental health treatment through innovative technologies, particularly in the areas of psychedelic medicine, neurotechnology, and precision psychiatry. Founded in 2020 by Dina Burkitbayeva, Greg Kubin, and Matias Serebrinsky, PsyMed Ventures began as a syndicate and has since evolved into a dedicated venture fund. In 2022, the firm launched a $25 million fund aimed at supporting early-stage startups that are pioneering new approaches to mental health. The fund's investments span a range of groundbreaking companies, including Freedom Biosciences and Delix Therapeutics, both of which are exploring the therapeutic potential of psychedelics. PsyMed's portfolio also includes companies working on advanced digital health platforms, novel drug formulations, and innovative neurotechnologies. PsyMed Ventures is particularly interested in companies at the pre-seed, seed, and Series A stages, believing that these early phases are where they can make the most significant impact. The firm emphasizes the importance of aligning with values-driven investors and entrepreneurs, recognizing that the mental health space requires long-term commitment and a collaborative approach.

Puget Sound Venture Club (PSVC) is Seattle's oldest angel investor group, founded in 1985 by Gary Ritner, who ran the club for 38 years and remains one of the most influential figures in Pacific Northwest angel investing. PSVC was founded with a straightforward mission: create a small, focused community of accredited investors who represent themselves or their organizations while providing access to the experience and insight of other members. The club's members invest in North American companies with an emphasis on the Pacific Northwest — Washington, Oregon, Idaho, and British Columbia — at seed, early-stage, and first-round stages across most industries, from consumer and food businesses through high-tech and TMT. Across 38 years of operation, PSVC members past and present collectively invested approximately $220 million into more than 1,350 companies, many of which went on to significant outcomes. Notable alumni and companies that have presented to the club include Starbucks, DocuSign, Coinstar (later Outerwall), Clarisonic, Insitu, Theo Chocolate, Julep, and Otonexus. In September 2023, PSVC merged its membership into the Alliance of Angels (AoA) — the largest angel group in the Pacific Northwest, with approximately 160 investors backing more than 20 tech startups per year — with PSVC's roughly 30 members becoming AoA members. Gary Ritner retained ownership of the PSVC brand and joined AoA's Board of Directors. PSVC's nearly four-decade track record represents one of the most durable angel investor networks in the US Pacific Northwest. Its merger with AoA consolidates the region's angel capital into a single platform with greater deal volume, deeper geographic coverage, and a stronger institutional voice for startup-friendly policy in the Washington State ecosystem. The PSVC community and its historical investment culture continue under the combined AoA umbrella.

Puhua Capital, established in 2004 and based in Hangzhou, China, is a prominent venture capital firm with a focus on early and mid-stage investments in cutting-edge technology sectors. The firm is particularly active in industries such as healthcare, semiconductors, energy, and artificial intelligence. Puhua Capital's investment strategy revolves around identifying high-potential startups in sectors like biotechnology, clean energy, and advanced manufacturing, often engaging in rounds ranging from $15M to $50M. Notably, the firm has been involved in significant deals such as investments in Pudu Robotics, a leader in autonomous delivery robots, and Pony.ai, an autonomous driving technology company. Puhua Capital also emphasizes innovation within health and deep tech, backing companies like Creavo Medical Technologies and Laser Link, which specialize in medical devices and optical communication technology, respectively. Led by CEO Shen Qinhua, the team at Puhua Capital leverages their extensive industry knowledge to help scale their portfolio companies both within China and internationally. The firm has a strong track record of successful exits, including IPOs, and maintains a forward-looking approach, investing in technologies poised to transform industries on a global scale​.

Pureos Bioventures is a venture capital firm focusing on investing in innovative biopharmaceutical companies. Pureos Bioventures targets early-stage to growth-stage companies developing novel therapeutic approaches and technologies in the life sciences sector. The firm is particularly interested in startups that aim to address unmet medical needs and provide transformative treatments for patients. Pureos Bioventures is known for its strategic investments and active involvement in the development of its portfolio companies. The firm leverages its extensive network and deep industry expertise to support the growth and success of the startups it invests in. The investment strategy of Pureos Bioventures typically involves significant initial investments, with the potential for follow-on funding as companies progress. This approach allows the firm to nurture and support its portfolio companies through various stages of development, from early research to clinical trials and commercialization. The team at Pureos Bioventures comprises experienced professionals with backgrounds in biotechnology, pharmaceuticals, and venture capital. Their combined expertise enables them to identify promising investment opportunities and provide valuable guidance and support to their portfolio companies. For startups looking to engage with Pureos Bioventures, it is essential to demonstrate innovative and impactful therapeutic solutions with strong potential for clinical and commercial success. Emphasizing a clear path to address unmet medical needs and the potential for significant patient impact will be key in attracting investment from Pureos Bioventures.

Purple Orange Ventures (POV) is a Berlin-based, entrepreneur-led impact seed fund founded in 2012 by Gary Lin. Focused on leveraging science and technology, the fund is dedicated to solving some of the world’s most pressing challenges, specifically aiming to remove animals from the global food system and ensure sustainable food production. POV targets early-stage startups that are pioneering food-tech, agri-tech, and biotech innovations across the globe. POV invests primarily in pre-seed, seed, and Series A stages, with typical investments ranging from €100K to €1.5M. The fund backs mission-driven founders developing technologies in areas such as plant-based foods, lab-grown meat, and sustainable agriculture. Its portfolio includes companies like BLUU Seafood (lab-grown fish), Omni (plant-based pet food), and Change Foods (animal-free dairy). These startups are transforming the food industry by offering sustainable alternatives to traditional animal products. In addition to financial backing, Purple Orange Ventures provides its portfolio companies with business development support, operational expertise, and access to a network of industry experts to help accelerate growth and achieve market leadership. The firm’s mission reflects its commitment to creating a more sustainable, animal-free food ecosystem, positioning itself as a leader in the alternative protein and food technology sectors.

Purple Ventures is a European venture capital firm primarily focused on investing in early-stage, software-enabled startups, particularly those in Central and Eastern Europe (CEE). Established by experienced entrepreneurs and ex-founders, Purple Ventures aims to partner with like-minded founders who are building innovative tech solutions with global scalability. The firm targets investments in pre-seed and seed stages, typically deploying between €100,000 to €1.5 million per company. Purple Ventures has a strong emphasis on software, AI, and deep tech, with a notable portfolio that includes companies like Tachyum, which is developing groundbreaking AI processors, and VOS.health, a mental health platform with millions of users. The firm’s investments span multiple sectors, from health tech and fintech to sustainability and the experience economy. Their support extends beyond financial investment, leveraging their extensive network and expertise to help startups scale globally. The team behind Purple Ventures brings deep operational experience, having built and scaled businesses themselves, which allows them to provide hands-on guidance to portfolio companies. With a clear mission to make a global impact through innovation, Purple Ventures is positioning itself as a key player in the European startup ecosystem, particularly within the fast-evolving tech landscape.

Purpose Built Ventures is a San Francisco-based venture studio founded in 2018 by three-time founder and investor Miles Lasater alongside two-time founder Taylor Thompson. Rather than receiving pitches, the firm partners directly with future founders, co-generates ideas, assembles teams, and commits capital to launch new companies from scratch. Lasater previously co-founded HigherOne (IPO 2010), SeeClickFix (acquired 2019), and OneUni, is a Kauffman Fellow, and sits on the board of ConnCorp's $150 million New Haven economic development project. Purpose Built operates across three thematic pillars — Health, Economic Opportunity, and Public Sphere — with sector depth in fintech, future of work, edtech, HR, proptech, and healthtech. The studio model involves founders working directly with the general partners for three to nine months; if both parties converge on a company idea, Purpose Built commits up to $500,000 against milestones. For external deals, it writes pre-seed and seed checks typically between $25,000 and $250,000. The firm leads rounds and has made 42 total investments, including one unicorn and six acquisitions. Notable portfolio companies include Coral Care (in-home pediatric developmental therapy, $5.2 million Seed led by Purpose Built alongside AlleyCorp), Wavely Diagnostics (at-home pediatric digital diagnostics), and Twill. Every company Purpose Built backs must help end users reach for economic opportunity — a defining filter that guides deal selection and shapes how the team works with founders beyond the initial check. The firm places equal emphasis on the personal and professional development of founders, treating operator mentorship as a core part of its value proposition.

PUSH Ventures is a Vienna, Austria-based early-stage venture capital firm founded in 2017 and co-led by Managing Partners Laurenz Simbruner and Lukas Puspok. The firm focuses on two core thematic areas: healthtech and climate technology, investing primarily at pre-seed and seed stage with follow-on capacity into Series A and B. Geographic emphasis is on Austria, Germany, and the broader European market. The firm closed its initial fund at approximately 20 million euros in July 2022. PUSH writes tickets ranging from roughly 100,000 euros to 1.5 million euros and selects startups on a disciplined evaluation of team quality, technology, and early traction. Across approximately 60 disclosed investments, the portfolio has produced seven acquisitions. Notable exits include Fernride (autonomous trucking), mySugr (diabetes data platform, acquired by Roche), and Zizoo (boat rental marketplace). Active portfolio companies include MOSTLY AI (synthetic data), Anyline (mobile OCR and data capture), 9amHealth, enspired (AI-driven energy trading), Mimo, and Valutico. The firm operates with a lean team of six people including three partners, structured under an SFDR-aligned investment process that reflects its environmental and health mission. PUSH positions itself as a hands-on early partner to founders, engaging deeply with team development, strategy, and follow-on fundraising across the Austrian and German startup ecosystems. Its dual focus on human health and planetary health gives it a coherent thesis that spans two of the most active categories in European venture, while the Vienna base provides direct access to an emerging DACH deep-tech talent pool.

Pymwymic, founded in 1994, is a Netherlands-based impact investment cooperative that channels capital into businesses driving positive environmental and social change. Known for its pioneering role in European impact investing, Pymwymic's mission is to blend financial returns with measurable impact, focusing primarily on sectors such as sustainable agriculture, ecosystem restoration, and food systems. Their investments are managed through SDG-aligned sub-funds like the Healthy Food Systems Impact Fund, which targets startups transforming the global food industry through sustainable technologies. Over the years, Pymwymic has invested more than €60 million into innovative companies, helping them scale while maintaining their social missions. Recent investments include Aurea Imaging, which enhances environmental monitoring using AI, and Weenat, which focuses on data-driven water management​. With over 150 co-owners, Pymwymic operates as a cooperative, bringing together families, entrepreneurs, and institutional investors to co-develop impactful ventures. Their approach emphasizes impact governance, requiring companies to meet specific KPIs related to social and environmental outcomes. This community-driven structure allows Pymwymic to foster deep relationships with its portfolio companies, ensuring that the businesses stay committed to their missions as they grow and that profit never overshadows the planet​.

Q Holdings Inc. is a venture capital and private equity firm founded in 2018, with a focus on seed, early, and growth-stage investments. Headquartered in Delaware, Q Holdings manages $2.9 billion in assets and has offices in major global cities including New York, San Francisco, London, Abu Dhabi, and Shanghai. The firm primarily invests in technology, media, real estate, and fintech sectors. Q Holdings has a diverse portfolio that includes companies like Coursera, Postmates, Snap Inc., Spotify, Polkadot, and Solana. Their strategy spans various industries, and they have been involved in over 136 IPOs and acquisitions, with notable exits including Uber, Airbnb, and Snowflake. Q Holdings also launched multiple venture funds, including "The Social Butterfly" and "Nova Meadows," aimed at early-stage technology companies, with a combined value of $237.5 million. The firm is also active in real estate, having recently acquired over six major assets, boosting their total capital to $4.5 billion. Their real estate projects span globally, with significant investments in both residential and commercial properties, particularly in the UAE. With a growing portfolio and strategic global presence, Q Holdings continues to be a major player in both venture capital and real estate investment.

Q Venture Partners is a venture capital firm established in 2016, headquartered in Hong Kong. The firm specializes in early-stage investments, particularly focusing on industries like consumer electronics, Internet of Things (IoT), artificial intelligence, and healthcare technologies. Q Venture Partners has a global outlook, investing primarily in North American and Asian markets, with a particular emphasis on scalable technologies that have the potential to transform industries. Led by co-founders Henry Tan and Larry Tsai, the firm adopts a hands-on approach, providing strategic guidance and support to its portfolio companies. The firm's investment strategy is focused on sectors where technology can create significant value, driving both innovation and market disruption. Notable investments include companies like StrongArm Tech, AREVO, and Preteckt, which are leaders in their respective fields of wearable technology, advanced manufacturing, and predictive maintenance software. Q Venture Partners is actively seeking new investments and typically participates in Series A and B funding rounds, often collaborating with other leading venture capital firms. The firm has a track record of successful exits, including the merger of AREVO in 2024, reflecting its ability to identify and nurture high-potential startups into market leaders.

QB1 Ventures is a New York-based venture capital firm founded in 2015 as the venture arm of Talpion Fund Management, the multi-asset family office led by Alex Swieca. The firm invests in US- and Israel-based technology companies across enterprise software, fintech, sports technology, consumer technology, and healthtech, seeking startups with scalable core technology that solves a genuine problem in a simplified way. Alex Swieca serves as Founder and Managing Partner, with Kevin Swieca as Venture Partner. QB1 targets Seed and Series A rounds with typical check sizes of $100,000 to $1 million and a sweet spot around $250,000, running a deliberately concentrated portfolio of roughly 10 companies rather than a high-volume fund. Named portfolio companies include WSC Sports (AI-powered sports highlight generation), Yellowdig (community learning platforms), Fan AI (sports fan data analytics), GameCo (skill-based gaming), mPrest (power-grid software), Percepto (industrial autonomous drones), ElMindA (brain analytics), Privasea (fully homomorphic encryption for privacy-preserving AI), and Replay Technologies, which was acquired by Intel. The most recent publicly documented exit was RecoverX, acquired by Hyperice in January 2021. The concentration of the portfolio is a deliberate strategic choice: QB1 prioritizes active engagement with each company over breadth of coverage, working closely with founders on strategy, network access, and follow-on fundraising. The firm's dual US-Israel mandate reflects the family office's existing ties to both markets and its view that Israeli deep technology and US market distribution create a natural and complementary investment pairing.

Qbic, established in 2012 and headquartered in St-Denijs-Westrem, Belgium, is a venture capital fund focused on early-stage investments, particularly in spin-offs from universities, research institutions, and hospitals. The fund supports startups in sectors such as deeptech, biotech, medtech, and software. Qbic has made significant contributions to transforming technological breakthroughs into sustainable businesses. Notable investments by Qbic include Theratrame, which focuses on cancer therapies, Animab, which develops alternatives to antibiotics for animals, and VoxelSensors, which specializes in 3D perception sensors for extended reality applications. Additionally, their portfolio includes companies like AmphiStar in the biotechnology field and Weave.ly in software development. Qbic manages around €200 million across its various funds, with Qbic III recently raising €88.5 million to continue supporting innovative spin-offs. The fund's strategic partners include major Belgian universities and research institutions, providing a strong pipeline of high-potential startups. The team at Qbic, led by Managing Partner Sofie Baeten, is dedicated to fostering technological innovation and supporting the growth of their portfolio companies.

QDNL Participations is a €15 million venture fund based in the Netherlands, dedicated to supporting early-stage quantum technology startups. Backed by the Quantum Delta NL initiative, the fund bridges the gap between academic research and venture capital, focusing on companies working in quantum computing, sensing, communication, and enabling technologies. Their mission is to help researchers transform their cutting-edge innovations into investable businesses. The fund typically invests up to €1.5 million per startup and offers additional pre-seed support of €50,000 to promising teams even before they have formally launched a company. Through its strategic support, QDNL Participations aims to build a sustainable quantum ecosystem in the Netherlands by 2028, providing not only financial backing but also commercial and business development expertise. Their portfolio includes companies like QphoX and Qblox, both leaders in the quantum field. With leadership from prominent figures like Managing Director Ton van 't Noordende and venture partner Chad Rigetti, the fund also offers a unique on-call support program called Infinity, designed to provide startups with access to over 800 deep-tech investors worldwide. This positions QDNL Participations as a key player in scaling quantum startups within Europe​.

QED Investors, founded in 2007 by Nigel Morris and Frank Rotman, is a leading venture capital firm based in Alexandria, Virginia. The firm focuses exclusively on fintech and has made significant contributions to the growth of the financial services sector. QED has invested in over 200 companies across 16 countries, including notable names like Credit Karma, ClearScore, SoFi, Nubank, Remitly, and AvidXchange. QED recently closed two new funds totaling $925 million: an early-stage fund and a growth-stage fund, bringing their total assets under management to over $4 billion. These funds allow QED to continue its mission of investing in disruptive fintech companies globally, with a particular focus on the U.S., Europe, Latin America, India, and Southeast Asia​. The firm is renowned for its hands-on approach, leveraging the extensive operational experience of its partners to provide in-depth support to its portfolio companies. This includes strategic guidance, operational support, and access to a wide network of industry experts. QED is committed to building long-term relationships with entrepreneurs and playing an active role in their growth and success​.

Qiming Venture Partners, founded in 2006, is a leading venture capital firm with a strong focus on investments in the technology, consumer, and healthcare sectors. The firm operates with a significant presence in China and the United States, managing over $9.5 billion in capital across 18 funds. Qiming has an impressive portfolio of successful investments, including prominent companies such as Xiaomi, Bilibili, Meituan, and Mindray. These companies highlight Qiming's ability to identify and support high-potential startups that grow into industry leaders. The firm typically invests in early and growth-stage companies, emphasizing sectors like internet and consumer products, healthcare, and technology​​. The investment strategy at Qiming is comprehensive, often providing extensive support to portfolio companies through strategic guidance and leveraging a vast network. Key team members, like Bonnie Wang, focus on internet and consumer investments and have been recognized for their contributions to the venture capital industry​​. With a commitment to fostering innovation and growth, Qiming Venture Partners continues to play a crucial role in the global venture capital landscape, especially within the dynamic markets of China and the U.S.

Qiming Venture Partners USA, launched in 2017, focuses on early-stage investments in healthcare, particularly therapeutics and healthcare technologies, across the U.S. and Europe. Backed by its China-based parent firm Qiming Venture Partners, the U.S. arm leverages both financial and human capital to support transformative innovations in healthcare, including drug development and digital health solutions. With over $550 million raised across three funds, Qiming USA has already invested in more than 30 companies and achieved notable exits through M&A and IPOs. Their strategy is centered on partnering with visionary healthcare entrepreneurs, offering not just capital but also deep technical expertise and a global network, including synergies with the broader Qiming platform in China. Key team members include managing partners like Mark McDade and the recent addition of Isaac Ciechanover, whose extensive background in biotech strengthens Qiming’s healthcare focus. Their third fund, closed at $260 million in 2022, continues to invest in innovative therapeutics and health tech ventures that have the potential to make a significant impact on patient outcomes​.

Quadia, founded in 2010 and based in Geneva, is a leading impact investment firm focused on financing solutions for a regenerative economy. They invest across sectors like clean energy, sustainable food systems, and circular production, with notable investments in companies like Fairphone, Infarm, and Ynsect. Quadia has allocated over €200 million to support transformative ventures primarily across Europe, with a strong focus on France and Switzerland. Their strategy revolves around Series A and growth-stage investments, providing equity and debt to businesses that align with their principles of social and environmental impact. Quadia looks for scalable companies that promote sustainable consumption and regenerative practices, focusing on long-term value creation. They often co-invest with partners like Bpifrance and Danone Manifesto Ventures, building a robust network to amplify the impact of their investments. The firm is led by a small but experienced team, including Guillaume Taylor, with operations extending to a secondary office in Paris. Their mission emphasizes generating attractive returns while advancing the ecological transition, making them a pioneer in Europe’s impact investing landscape​.

Quake Capital, founded in 2016, is a venture capital firm and accelerator headquartered in Seattle, Washington, with a strong presence in New York and Los Angeles. The firm focuses on seed-stage investments, offering substantial support to new and early-stage ventures across a wide range of industries. Through their accelerator program, Quake Capital provides startups with resources, mentorship, and funding to help them grow and succeed. The firm has made over 300 investments in various sectors, including digital health, fintech, AR/VR, gaming, and e-commerce. Notable portfolio companies include NOCD, which offers online therapy for OCD; Blok Party, a platform combining physical, digital, and social play; Vyrill, a user-generated video content discovery and marketing platform; and Grain, which helps individuals build credit through savings. Quake Capital's investment strategy is industry-agnostic, emphasizing innovation and potential for growth. They typically invest $100,000 to $150,000 in each startup that completes their accelerator program. The firm’s founders, Glennon Argenbright, Chad Burgess, Adam Cragg, and Brandon Maier, bring extensive experience in venture capital and entrepreneurship, providing valuable insights and support to their portfolio companies.

Qualcomm Ventures, founded in 2000, is the corporate venture capital arm of Qualcomm Incorporated, headquartered in San Diego, California. The firm focuses on investing in early to growth-stage companies in sectors such as artificial intelligence (AI), automotive, mobile, enterprise and cloud, and smart systems. It supports startups with strategic guidance, leveraging Qualcomm’s extensive technological expertise and global network. Notable investments from Qualcomm Ventures include companies like Cloudflare, Xiaomi, Zoom, and SentinelOne. These companies have achieved significant milestones, including successful IPOs and high-profile acquisitions. For instance, SentinelOne went public in June 2021, and Zoom became a key player in cloud video conferencing and communication services. Qualcomm Ventures manages over $2 billion in assets and has a portfolio of more than 360 companies, with 22 unicorns and 19 companies that have gone public. The firm is also active in fostering innovation through specific funds like the Qualcomm Ventures AI Fund and the 5G Ecosystem Fund, which target emerging technologies in AI, machine learning, and 5G solutions. The investment team is composed of experienced professionals located in various global regions, including the US, China, and Israel, ensuring a broad and strategic reach to identify and support high-potential startups worldwide​.

Quantonation is a pioneering venture capital fund focused on early-stage investments in quantum technologies and deep physics. Founded in 2018, the Paris-based fund is dedicated to supporting startups working in quantum computing, quantum communications, quantum sensing, and related fields, aiming to accelerate the commercial adoption of groundbreaking scientific innovations. With over €91 million raised in its first fund, Quantonation has backed more than 30 companies, including notable names like Pasqal, ORCA Computing, and Qubit Pharmaceuticals. The fund's strategy targets startups at the pre-seed and seed stages, emphasizing those with the potential to transition quantum innovations into practical, industry-ready applications. These companies address critical areas such as molecular design, high-performance computing, and cybersecurity, with broader impacts expected in fields like healthcare, energy, and climate change mitigation. Quantonation leverages its deep scientific expertise and global network of research institutions, including partnerships with MIT, Ecole Polytechnique, and Oxford University. Quantonation has recently launched its second fund, Quantonation II, with a target of €200 million, signaling its commitment to expanding its support for quantum startups worldwide. Led by a team of experienced scientists and investors like Christophe Jurczak and Olivier Tonneau, the firm is actively shaping the future of the quantum tech ecosystem.

QIC (Queensland Investment Corporation) is a prominent institutional investment manager based in Queensland, Australia. Established in 1991, QIC manages diverse multi-asset portfolios on behalf of the Queensland Government and private institutional clients. The firm's investment focus spans infrastructure, real estate, private equity, private debt, and liquid markets. QIC’s long-term strategy is built around harnessing global megatrends like sustainability, climate resilience, and digital transformation to deliver robust, long-term returns for its investors. As part of its mission to foster innovation and economic growth, QIC manages the Queensland Venture Capital Development Fund (QVCDF), which was launched to bolster the state's venture capital ecosystem. The QVCDF provides matched funding and accelerator programs to support early-stage and growth-stage startups in Queensland, allowing them to scale within the state. The fund is committed to building a strong venture capital industry in Queensland by partnering with VCs such as Antler, Main Sequence, and Sprint Ventures. The QVCDF focuses on sectors like AI, climate tech, healthcare, and automation, positioning Queensland as a leader in digital healthcare and sustainability. Recent investments include backing startups like Vapar, Avarni, and Emesent, which are driving innovation in fields ranging from drone technology to climate action. With over $130 million committed to the fund, QIC is ensuring that Queensland startups have the capital and support needed to grow, scale, and make a global impact while remaining rooted in the state​.

Quest Venture Partners, based in Silicon Valley, excels in early-stage investments, typically ranging from $100,000 to $1.5 million, with a focus around $500,000. They are often the first institutional investors, backing startups in digital media, mobile, and new tech sectors. Notable investments include Amplitude, Coffee Meets Bagel, and Neurable, demonstrating their knack for identifying high-potential companies. Quest’s strategy is hands-on, supporting founders through initial growth stages with strategic guidance. They prioritize startups with innovative ideas and strong teams, fostering a collaborative environment to drive success. The firm is led by Managing Partners Andrew Ogawa, Maarten 't Hooft, and Marcus Ogawa, who bring diverse expertise from Daimler AG, Google, and the mobile/digital media sectors, respectively. This blend of experience helps Quest provide substantial value and insight to their portfolio companies. Quest Venture Partners is globally focused, leveraging their Silicon Valley base to invest in scalable, innovative startups worldwide. Their active involvement and strategic approach make them a preferred partner for early-stage ventures aiming for significant impact.

Quest Ventures is a leading venture capital firm focused on driving the digital economy across Asia. Founded in 2011 by James Tan and Wang Yunming, Quest Ventures invests primarily in early-stage startups within sectors such as artificial intelligence, e-commerce, fintech, logistics, media, and more. The firm is renowned for being one of the first investors in many startups, providing the critical early funding that enables these companies to scale and disrupt their industries. With its headquarters in Singapore and a significant presence in Southeast Asia, Quest Ventures has supported over 100 companies, including notable names like Carousell, ShopBack, 99.co, and StyleTheory. The firm's investment strategy includes thematic funds such as the Asia Fund, Metaverse Fund, and Decarbonisation Fund, focusing on areas like Web 3.0 technologies and environmental sustainability. Quest Ventures also operates investment syndicates, allowing accredited investors to participate in funding rounds of promising startups. This approach has enabled Quest Ventures to build a robust network of mentors, executives, and investors who provide strategic support and market insights to portfolio companies.

Quidnet Ventures is a New Zealand deep-tech venture capital firm founded in 2019 and based in Auckland. The firm invests exclusively in scalable, capital-efficient New Zealand-based businesses with global ambition from day one, spanning material science, medical devices, agritech, data services, IoT, climate tech, biotech, semiconductors, and AI. Quidnet is led by Founder and General Partner Dr. Mark Bregman, a physicist with 30 years of technology experience including 16 years leading research and innovation at IBM and subsequent CTO-level roles at major enterprises. Quidnet leads rounds and writes seed-stage cheques of $100,000 to $500,000, with a typical average around $300,000. Fund I has been fully deployed; Fund II is targeted at approximately $25 million, roughly five times the size of Fund I. The firm has 8 portfolio companies to date. Notable investments include Marama Labs (deep-tech spectroscopy), Ambit (AI conversational platform), Arcanum AI (AI automation), RosterLab (workforce rostering software), Litmaps (science research software), and Advemto (photonics technology). Quidnet is affiliated with Icehouse Ventures' broader New Zealand startup platform. Dr. Bregman's differentiated value proposition is opening US distribution channels, advisor networks, and talent pools to Kiwi deep-tech companies — a form of market-access support that few New Zealand investors can credibly deliver. The firm works closely with founders for years prior to investment, establishing trust and technical alignment before committing capital. This patient, relationship-first approach, combined with Silicon Valley-grade operating experience applied to the New Zealand ecosystem, defines Quidnet's edge as the country's leading deep-tech seed investor.

Quiet Capital, founded in 2017 and based in San Francisco, is a technology-focused venture capital firm. They invest in early-stage companies, spanning sectors such as fintech, software, cybersecurity, health and wellness, and AI. Their diverse portfolio includes notable companies like MoonPay, DuckDuckGo, Mercury, Reddit, and Substack. Quiet Capital typically invests from pre-seed to Series D stages, aiming to support remarkable founders from day zero. They have made 263 investments and achieved 11 notable exits, including Reddit and Atom Finance. Their investment strategy is centered on backing innovative technologies and scalable business models across a variety of industries. The firm is managed by a team of experienced partners including Ben Mahdavi, Co-Founder and Managing Partner, and Christopher Capozzi, Partner and CFO. They are known for their hands-on approach, providing strategic support and leveraging their extensive network to help portfolio companies grow. For startups looking to engage with Quiet Capital, demonstrating strong innovation, scalability, and a clear market need is essential. Connecting through their network or via their platform can improve the chances of securing investment.

Quona Capital, founded in 2014 and headquartered in Washington, D.C., is a venture capital firm focused on fintech innovation in emerging markets. They invest primarily in Latin America, Africa, MENA, South, and Southeast Asia, targeting financial inclusion and positive social impact. Notable investments include Coins.ph, a Philippines-based cryptocurrency exchange; IndiaMART, a B2B marketplace; and ZestMoney, a fintech company offering credit to underserved consumers in India. Quona's strategy emphasizes early to growth-stage investments in companies that leverage technology to improve financial services for underserved populations. They typically lead funding rounds and provide follow-on investments to support scaling efforts. The firm's average check size ranges from $1M to $10M, and they actively collaborate with co-investors like Accion and QED Investors. Key team members include co-founders Monica Brand Engel, Jonathan Whittle, and Miguel Herrera. The team is known for their deep expertise in fintech and emerging markets, providing strategic support to portfolio companies. Startups seeking to engage with Quona should highlight scalable, tech-driven solutions that enhance financial access and inclusion.

Qure Ventures is Israel's first venture capital fund dedicated exclusively to digital health, founded in 2012 and headquartered in Herzliya. In November 2016 the firm launched a flagship $50 million vehicle in partnership with equity crowdfunding platform OurCrowd, sometimes branded as OurCrowd Qure. The fund invests predominantly in Israel-based digital health startups across Seed, Series A, and selective Series C follow-ons, with an explicit thesis to fund deep-tech solutions that improve patient care, reduce healthcare delivery costs, create data transparency, and empower health consumers. The fund is led by Managing Partners Dr. Yossi Bahagon — founder and CEO of Luminox Health, acquired by OurCrowd, and a recognized digital health expert — and Allen Kamer, co-founder of Humedica, which was acquired by UnitedHealth Group in 2013. Across 12 portfolio companies, notable names include Tyto Care (remote clinical exam kit), DarioHealth (IPO), Zebra Medical Vision (acquired by Nanox), and Carevive, which was acquired by Health Catalyst in June 2024. The portfolio has produced one IPO and three acquisitions in total. Qure's defining operating philosophy is hands-on engagement: roughly 70 percent of team time is devoted to supporting portfolio companies on strategy, business development, growth, and follow-on fundraising. Strategic partnerships spanning consumer, provider, payer, and pharma channels help portfolio companies access clinical-trial pipelines and commercial distribution faster than they could independently. This partnership-intensive model, combined with deep domain expertise in Israeli health technology, positions Qure as a category specialist in one of the world's leading digital health ecosystems.

R/GA Ventures is the investment and innovation arm of R/GA, a global digital agency. Founded in 2013, the firm supports early-stage startups through accelerator programs and offers financial, creative, and relationship capital. Notable investments include Latch, Happy Returns, and Transmit.Live. R/GA Ventures focuses on sectors such as IoT, commerce, retail, marketing tech, sports, and media tech. Their unique approach includes connecting startups with R/GA's extensive global network, providing strategic guidance and resources to help startups scale and succeed.

R3i Ventures is the venture arm of R3i Capital, a female-owned venture capital and advisory firm founded in 2021 with its primary headquarters in Singapore and additional presence in Luxembourg and Silicon Valley. The firm focuses on patent-backed artificial intelligence and emerging-technology companies, investing globally across Asia-Pacific, Europe, and the Americas. R3i is led by Founder and General Partner Leesa Soulodre, alongside Prof. Marianne Winslett, who brings 30-plus years in trustworthy systems, data science, and high-performance computing and served as founding director of the Advanced Digital Sciences Center in Singapore from 2009 to 2013. R3i Future Fund LP is a roughly $50 million deeptech seed-stage vehicle targeting climate and healthcare opportunities via accelerator programs in Singapore, Luxembourg, and Texas. Sector focus spans applied AI, space, security, renewable energy, medtech, watertech, agriculture, advanced manufacturing, robotics, and semiconductors. Across its broader platform, R3i reports $184 million invested into 39 portfolio companies, $156 million returned across 16 exits, and approximately $2.4 billion of capital mobilized alongside $1.1 billion in non-dilutive grant funding. Notable portfolio companies include Quantum Brilliance (room-temperature quantum computing), ViewMind (brain-health diagnostics), and Prosoma (digital therapeutics). Ecosystem partners include Enterprise Singapore, Microsoft, Amazon, and NVIDIA. In April 2024, R3i launched R3i Frontier, a Venture Partner Investment Program designed for seven angel investors and emerging managers building track records in climate-deeptech. This platform extension reflects the firm's broader mission to build the funding infrastructure for frontier technology across underserved regions and asset classes, combining direct investment with ecosystem-development activities that amplify its capital with institutional and government partnerships.